Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lucas P. Nacusi"'
Autor:
Janeen H Trembley, Gretchen M Unger, Vicci L Korman, Md Joynal Abedin, Lucas P Nacusi, Rachel I Vogel, Joel W Slaton, Betsy T Kren, Khalil Ahmed
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e109970 (2014)
Protected and specific delivery of nucleic acids to malignant cells remains a highly desirable approach for cancer therapy. Here we present data on the physical and chemical characteristics, mechanism of action, and pilot therapeutic efficacy of a te
Externí odkaz:
https://doaj.org/article/8ba3a800ed764abfb326c8718b911d34
Autor:
Khalil Ahmed, Rachel Isaksson Vogel, Daniel P. Shaughnessy, Scott M. Dehm, Cheryl L. Zimmerman, Janeen H. Trembley, Gretchen M. Unger, Md. Joynal Abedin, Lucas P. Nacusi, Vicci L. Korman, Gloria A. Niehans, Yingming Li, Betsy T. Kren
Publikováno v:
Oncotarget
// Khalil Ahmed 1, 2, 3, 6, * , Betsy T. Kren 1, 2, 6, * , Md. Joynal Abedin 1, 2, * , Rachel I. Vogel 4, 6 , Daniel P. Shaughnessy 1, 2 , Lucas Nacusi 7 , Vicci L. Korman 7 , Yingming Li 2 , Scott M. Dehm 2, 3, 6 , Cheryl L. Zimmerman 5 , Gloria A.
Autor:
Ji Lu, Travis Vander Steen, Farhad Kosari, Lucas P. Nacusi, Haojie Huang, George Vasmatzis, Lucy J. Schmidt, Peter E. Lonergan, Steven P. Balk, George G. Klee, Zhifu Sun, Donald J. Tindall, Liguo Wang, Chunxi Wang, Stephen A. Boorjian
Publikováno v:
Journal of Urology. 193:690-698
Spliced variant forms of androgen receptor were recently identified in castration resistant prostate cancer cell lines and clinical samples. We identified the cistrome and gene signature of androgen receptor splice variants in castration resistant pr
Autor:
Donald J. Tindall, Lucas P. Nacusi
Publikováno v:
Expert Review of Endocrinology & Metabolism. 4:417-422
The androgen receptor (AR) plays a critical role in prostate cancer (PCa) development and progression. Despite the success of androgen-deprivation therapy, remission occurs in almost all cases. This stage of the disease is called castration-recurrent
Autor:
Paul J. Leibson, Renee A. Schoon, Christopher J. Dick, Lucas P. Nacusi, Colin M. Segovis, Daniel D. Billadeau
Publikováno v:
The Journal of Immunology. 182:6933-6942
The NK cell-activating receptor NKG2D plays a critical role in the destruction of malignant cells, but many of the cell-signaling mechanisms governing NKG2D-mediated cellular cytotoxicity are unknown. We have identified an NKG2D-mediated signaling pa
Autor:
Jeffrey C. Nolz, Daniel D. Billadeau, Yoji Shimizu, Rebecca Vasconcellos Botelho de Medeiros, Colin M. Segovis, Lucas P. Nacusi, Jason S. Mitchell
Publikováno v:
The Journal of Cell Biology
WAVE2 regulates T cell receptor (TCR)–stimulated actin cytoskeletal dynamics leading to both integrin clustering and affinity maturation. Although WAVE2 mediates integrin affinity maturation by recruiting vinculin and talin to the immunological syn
Autor:
Lucas P. Nacusi, Robert J. Sheaff
Publikováno v:
Pancreatology. 7:373-377
Disrupted cell cycle machinery is commonly thought to result in loss of proliferative control. Standard therapies target these rapidly dividing cells, yet they are ineffective against pancreatic cancer, suggesting that its development and/or progress
Publikováno v:
Biochemistry. 44:14553-14564
Multiple proteolytic pathways are involved in the degradation of the cyclin-dependent kinase inhibitor p21(Cip1/WAF1). Timed destruction of p21(Cip1/WAF1) plays a critical role in cell-cycle progression and cellular response to DNA damage. The SCF(Sk
Autor:
Lucas P. Nacusi, Jose D. Debes
Publikováno v:
Pancreatology. 8:422-424
Nuclear receptors (NRs) are ligand-activated transcription factors that regulate gene expression. These receptors share a quite similar structure and mechanism of action. Upon ligand binding, NRs translocate from the cytoplasm to the nucleus and bind
Autor:
Lucas P. Nacusi, Vicci L. Korman, Gretchen M. Unger, Diane K. Tobolt, Alvaro Mendoza, Alex J. Pretti
Publikováno v:
Cancer Research. 76:3746-3746
A high initial priming dose of the novel RNAi therapeutic GS-10 was investigated as a strategy to elevate important RISC complex proteins that have the potential to increase efficacy of subsequent RNAi treatment regimens in solid tumor cancers. GS-10